Annotation Detail for CASQ1

Basic Information
Top
| Desease ID | Desease Name |
|---|
| 1879 | Glucose intolerance |
| 1904 | Diabetes mellitus |
| 2186 | Achalasia and cardiospasm |
| Desease Name |
|---|
| METABOLIC |
| diabetes, type 2 |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of CASQ1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
| D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of CASQ1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D001943 |
Breast Neoplasms |
|
Chromium |
3.42 | 15986119 |
| MESH:D007674 |
Kidney Diseases |
|
Chromium |
4.15 | 17934191 |
PharmGKB Accession:PA26095
| Releated drug ID |
Related drug Name |
| PA452249 | antiarrhythmics, class i and iii |